is testing a new vaccine that inoculates against Covid and flu amid sluggish uptake of both shots.The first patient was given the two-in-one vaccine this week as clinical trials got underway. In total 180 patients will be recruited for the study.Pfizer's new shot targets the Omicron variant and its offshoots as well as four strains of influenza.
Load More
Load More